M
50
-2
DE
46
-3
LOW
49
3
DHR
62
-2
TXN
48
-22
OI
60
10
EMR
59
-5
PYPL
50
-24
STI
5
-41
CVS
33
-2
KR
44
15
V
50
-26
SWKS
53
-15
RCL
62
-18
XOM
48
-17
SE
41
-38
CMG
56
6
F
56
-6
TMO
56
-11
WFC
74
-16
M
50
-2
DE
46
-3
LOW
49
3
DHR
62
-2
TXN
48
-22
OI
60
10
EMR
59
-5
PYPL
50
-24
STI
5
-41
CVS
33
-2
KR
44
15
V
50
-26
SWKS
53
-15
RCL
62
-18
XOM
48
-17
SE
41
-38
CMG
56
6
F
56
-6
TMO
56
-11
WFC
74
-16
Financhill
Back

PubMatic, Inc. Vs. CRISPR Therapeutics AG Industry Stock Comparison

Sell
27

PUBM
PubMatic, Inc.

Last Price:
$9.04
Seasonality Move:
6.51%
Sell
43

CRSP
CRISPR Therapeutics AG

Last Price:
$55.22
Seasonality Move:
14.46%
Sell
27
PubMatic, Inc. (PUBM) is a Sell

Is PubMatic, Inc. a Buy, Sell or Hold?

  • The current PubMatic, Inc. [PUBM] share price is $8.92. The Score for PUBM is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • PUBM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $54.74. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PUBM Stock Price Chart

What is PubMatic, Inc.'s stock price today?

  • The PubMatic, Inc. share price today is $8.92
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PUBM is experiencing selling pressure, which indicates risk of future bearish movement.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $54.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.

PUBM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.71 Buy
Relative Strength Index (14 RSI): 49.82 Sell
Chaikin Money Flow: -321574 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.83 - 9.29) Sell
Bollinger Bands (100): (7.87 - 9.87) Buy

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 45.45 Sell
Chaikin Money Flow: -1078798 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.55 - 56.85) Buy
Bollinger Bands (100): (52.52 - 65.44) Sell

PUBM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.02 Sell
20-day SMA: 8.99 Sell
50-day SMA: 8.7 Buy
200-day SMA: 9.84 Sell
8-day EMA: 1.98 Buy
20-day EMA: 0.85 Buy
50-day EMA: 0.35 Buy
200-day EMA: 0.09 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.72 Sell
20-day SMA: 54.52 Buy
50-day SMA: 59.78 Sell
200-day SMA: 50.98 Buy
8-day EMA: 56.04 Sell
20-day EMA: 55.88 Sell
50-day EMA: 56.44 Sell
200-day EMA: 37.2 Buy

PubMatic, Inc. Earnings Growth & PUBM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.55 per share, and a decrease next year of $0.07 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

PubMatic, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):